Department of Pathology,
Human Oncology and Pathogenesis Program
Michael F Berger has not added Biography.
If you are Michael F Berger and would like to personalize this page please email our Author Liaison for assistance.
Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarrays.
Nature genetics Dec, 2004 | Pubmed ID: 15543148
Protein binding microarrays (PBMs) for rapid, high-throughput characterization of the sequence specificities of DNA binding proteins.
Methods in molecular biology (Clifton, N.J.) , 2006 | Pubmed ID: 16888363
Compact, universal DNA microarrays to comprehensively determine transcription-factor binding site specificities.
Nature biotechnology Nov, 2006 | Pubmed ID: 16998473
Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae.
Genome research Apr, 2007 | Pubmed ID: 17322287
Inferring condition-specific transcription factor function from DNA binding and gene expression data.
Molecular systems biology , 2007 | Pubmed ID: 17437025
Microarray analyses of newborn mouse ovaries lacking Nobox.
Biology of reproduction Aug, 2007 | Pubmed ID: 17494914
Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences.
Cell Jun, 2008 | Pubmed ID: 18585359
Design of compact, universal DNA microarrays for protein binding microarray experiments.
Journal of computational biology : a journal of computational molecular cell biology Sep, 2008 | Pubmed ID: 18651798
The Vibrio harveyi master quorum-sensing regulator, LuxR, a TetR-type protein is both an activator and a repressor: DNA recognition and binding specificity at target promoters.
Molecular microbiology Oct, 2008 | Pubmed ID: 18681939
Predicting the binding preference of transcription factors to individual DNA k-mers.
Bioinformatics (Oxford, England) Apr, 2009 | Pubmed ID: 19088121
Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells.
Cancer research Jan, 2009 | Pubmed ID: 19147588
High-resolution DNA-binding specificity analysis of yeast transcription factors.
Genome research Apr, 2009 | Pubmed ID: 19158363
Universal protein-binding microarrays for the comprehensive characterization of the DNA-binding specificities of transcription factors.
Nature protocols , 2009 | Pubmed ID: 19265799
Diversity and complexity in DNA recognition by transcription factors.
Science (New York, N.Y.) Jun, 2009 | Pubmed ID: 19443739
Applications of genomics in melanoma oncogene discovery.
Hematology/oncology clinics of North America Jun, 2009 | Pubmed ID: 19464593
Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts.
Genome biology , 2009 | Pubmed ID: 19835606
Conservation and regulatory associations of a wide affinity range of mouse transcription factor binding sites.
Genomics Apr, 2010 | Pubmed ID: 20079828
Integrative analysis of the melanoma transcriptome.
Genome research Apr, 2010 | Pubmed ID: 20179022
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo.
The EMBO journal Jul, 2010 | Pubmed ID: 20517297
Objective sequence-based subfamily classifications of mouse homeodomains reflect their in vitro DNA-binding preferences.
Nucleic acids research Dec, 2010 | Pubmed ID: 20705649
Notch and MAML-1 complexation do not detectably alter the DNA binding specificity of the transcription factor CSL.
PloS one , 2010 | Pubmed ID: 21124806
The genomic complexity of primary human prostate cancer.
Nature Feb, 2011 | Pubmed ID: 21307934
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Aug, 2011 | Pubmed ID: 21383288
The mutational landscape of head and neck squamous cell carcinoma.
Science (New York, N.Y.) Aug, 2011 | Pubmed ID: 21798893
Molecular mechanism underlying the regulatory specificity of a Drosophila homeodomain protein that specifies myoblast identity.
Development (Cambridge, England) Mar, 2012 | Pubmed ID: 22296846
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature Mar, 2012 | Pubmed ID: 22460905
High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.
Cancer discovery Jan, 2012 | Pubmed ID: 22585170
Melanoma genome sequencing reveals frequent PREX2 mutations.
Nature May, 2012 | Pubmed ID: 22622578
Genome sequencing identifies a basis for everolimus sensitivity.
Science (New York, N.Y.) Oct, 2012 | Pubmed ID: 22923433
BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer.
Cancer Feb, 2013 | Pubmed ID: 22930283
Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2013 | Pubmed ID: 23444215
Punctuated evolution of prostate cancer genomes.
Cell Apr, 2013 | Pubmed ID: 23622249
Copyright © 2025 MyJoVE Corporation. All rights reserved
We use cookies to enhance your experience on our website.
By continuing to use our website or clicking “Continue”, you are agreeing to accept our cookies.